FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION

项目摘要 药物发现、开发和翻译论坛提供了一个独特的 思想领袖和利益相关者之间的对话和合作平台 政府、学术界、工业界、基金会和患者倡导。论坛带来了 来自生物医学和临床研究的私营部门赞助商的领导人齐聚一堂， 赞助和管理生物医学和临床研究的联邦机构 学术界和患者，这样做的目的是教育政策 关于科学和政策交叉的问题的社区。目的是为了 鼓励跨部门和机构的对话和讨论，并阐明 问题，但不一定能解决问题。论坛成员身份确定它所关注的主题 希望在工作人员的协助下，举办公共会议，内部 讨论、座谈和合作。论坛不提供建议或 对任何政府悬而未决的具体问题或政策的建议 机构；总结报告将由公开会议产生。 论坛每年召开几次会议，以确定和讨论关键问题和 药物发现、开发和翻译方面的战略。以补充 除了成员的观点和专业知识外，论坛还举办公开研讨会，以 广泛吸纳专家、公众和政策界人士参与。这个 论坛的公开会议将公众的大量注意力集中在毒品的关键领域 发展。会议纪要会以印刷品形式向公众发放。 报道和互联网。除了大型公共讲习班外，论坛的活动还包括 关于生物医学科学和政策以及公众参与的系列讨论 药物开发进程，这为政策制定者提供了机会， 意见领袖，和公众在非正式的环境中。论坛成员的组合 外部专家由几个工作组组成，这些工作组审查高优先级问题 深度。此外，论坛委托或开发文件，以开展新的 研究和综合现有文献，探索科学和政策问题 在选定的主题上。论坛还促进其成员之间的合作，并 选民。

Project Summary The Forum on Drug Discovery, Development, and Translation provides a unique platform for dialogue and collaboration among thought leaders and stakeholders in government, academia, industry, foundations, and patient advocacy. The Forum brings together leaders from private sector sponsors of biomedical and clinical research, federal agencies sponsoring and regulating biomedical and clinical research, the academic community, and patients, and in doing so serves to educate the policy community about issues where science and policy intersect. The purpose is to encourage dialogue and discussion across sectors and institutions, and to illuminate issues, but not necessarily resolve them. The Forum membership identifies topics that it wishes to address, and with assistance from staff, develops public meetings, internal discussions, symposia, and collaborations. The Forum does not provide advice or recommendations on any specific issue or policy pending before any government agency; summary reports will result from the public conferences. The Forum convenes several times each year to identify and discuss key problems and strategies in the discovery, development, and translation of drugs. To supplement the perspectives and expertise of its members, the Forum also holds public workshops to engage a wide range of experts, members of the public, and the policy community. The Forum's public meetings focus substantial public attention on critical areas of drug development. Summaries of these meetings are disseminated to the public via printed reports and the internet. In addition to large public workshops, Forum activities include discussion series addressing biomedical science and policy, and public engagement in the drug development process, which provide opportunities to engage policymakers, opinion leaders, and the public in an informal setting. A combination of Forum members and outside experts comprise several workgroups that examine high-priority issues in depth. In addition, the Forum commissions or develops papers to undertake new research as well as synthesize existing literature and explore scientific and policy issues on selected topics. The Forum also fosters collaborations among its members and constituencies.